Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

This is a heart rhythm problem. It's a type of fast heart rate that can happen during exercise or when stressed. It's caused by the body's natural stress hormones (catecholamines). It can sometimes lead to a more dangerous fast heart rate called ventricular fibrillation.

ConditionRare Disease

What people with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) report

Every report comes from a Lived member, sent anonymously.

Have you tried Nadolol for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?

NameHow it went

About Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

What It Is

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited heart rhythm disorder. When the body releases adrenaline and related stress hormones (catecholamines) during exercise or strong emotion, the lower chambers of the heart can start beating very fast and irregularly. This is called ventricular tachycardia. A short episode can cause a racing or pounding heartbeat, lightheadedness or fainting. A longer one can turn into ventricular fibrillation, a chaotic rhythm in which the heart stops pumping, which causes cardiac arrest. What makes CPVT hard to recognize is that the heart looks normal. Its structure is healthy on imaging, and a standard ECG (electrocardiogram, a recording of the heart's electrical activity) taken at rest is usually normal. Symptoms most often begin in childhood or the teenage years, though some people are first diagnosed in their 20s or 30s. CPVT is rare, estimated at about 1 in 10,000 people, but it is an important cause of sudden death in young people whose hearts appear normal, and treatment greatly lowers that risk.

Causes & Risk Factors

CPVT is caused by a change (variant) in a gene that controls how heart muscle cells store and release calcium, the signal that makes each heartbeat contract. When that system leaks calcium under the influence of adrenaline, it can set off extra beats that build into a dangerous rhythm. The RYR2 gene accounts for about half or more of cases, and the CASQ2 gene for about 5%. A few other genes are rare causes, and in some people no gene change is found. RYR2-related CPVT needs only one altered copy of the gene, so a parent with the variant has a 50% chance of passing it to each child. It can also arise new in a person with no family history. CASQ2-related CPVT usually requires two altered copies, one from each parent, who are typically healthy carriers. A family history of fainting during exercise, unexplained drowning or sudden death at a young age can be a clue. The gene change is the cause. Exercise, sports, sudden excitement, fear, anger and other strong emotions are triggers that bring on episodes in someone who already has the condition. Dehydration, mineral imbalances in the blood and overheating can also make episodes more likely.

How It's Diagnosed

CPVT is suspected when someone faints, or has what looks like a seizure, during exercise or a burst of emotion. Because the resting ECG and heart imaging are usually normal, these episodes are often first blamed on ordinary fainting or epilepsy, and diagnosis is delayed by about two years on average. The key test is an exercise stress test, in which the person walks or runs on a treadmill while the heart rhythm is recorded. In CPVT, extra beats typically appear as the heart rate climbs, often above about 100 to 130 beats per minute, and become more complex with harder effort. A pattern in which the direction of each beat alternates on the ECG (bidirectional ventricular tachycardia) is especially characteristic. A normal exercise test does not rule CPVT out, because it shows the problem in only about two-thirds of people with the condition. A wearable monitor such as a Holter, an implanted loop recorder, or a carefully supervised infusion of an adrenaline-like medicine can help when exercise testing is not possible or is unrevealing. An echocardiogram or heart MRI checks for structural disease that could explain the symptoms instead. Genetic testing is recommended when CPVT is suspected. Finding a disease-causing variant confirms the diagnosis and allows relatives to be tested for that same variant. Results need expert interpretation, since rare harmless changes in the RYR2 gene are fairly common. Parents, siblings and children of an affected person should be evaluated, with genetic testing where a family variant is known and with exercise testing and rhythm monitoring in any case. Some children have a normal exercise test early on and develop findings later, so testing is repeated over time.

Treatment Options

There is currently no cure for CPVT, but treatment is aimed at keeping the heart rate and adrenaline surges below the level that sets off dangerous rhythms, and it substantially reduces the risk of cardiac arrest. Care is usually led by a cardiologist who specializes in heart rhythm, often at a center experienced with inherited arrhythmias. A beta-blocker, a medicine that blunts the effect of adrenaline on the heart, is the foundation of treatment and is taken lifelong. Nadolol is the preferred choice, with propranolol as an alternative; these are non-selective beta-blockers, which block adrenaline at more receptor types than those concentrated in the heart, and studies suggest they protect better than heart-selective types. The dose is raised to the highest level a person tolerates, and side effects such as tiredness are part of that balance. Taking the medicine every day matters a great deal: missed doses are a well-documented cause of fatal events. Relatives who carry the gene variant but have no symptoms are often offered a beta-blocker too. If episodes or exercise-test arrhythmias continue despite a beta-blocker, which happens in up to about a third of people, flecainide is usually added. It is an antiarrhythmic medicine that, in CPVT, appears to calm the calcium leak inside heart cells. It clearly reduces arrhythmias on exercise testing, but long-term evidence that it prevents cardiac arrest is still limited, and it is used together with a beta-blocker rather than in place of one when a beta-blocker can be taken. When medicines are not enough or cannot be tolerated, left cardiac sympathetic denervation (LCSD) may be offered. This is a keyhole chest operation that cuts some of the nerves carrying adrenaline signals to the heart. In the largest series, it sharply reduced serious events, but about a third of people still had a recurrence, so it adds protection rather than replacing medicine. An implantable cardioverter-defibrillator (ICD) is a device placed under the skin that detects a life-threatening rhythm and delivers a shock to restore it. It is generally recommended after a survived cardiac arrest, or when serious episodes continue despite full treatment. In CPVT the decision is more complicated than in many heart conditions: the pain and fear of a shock can release more adrenaline and trigger further arrhythmias, unnecessary shocks are common, and device problems add up over a young person's lifetime. Specialists now weigh an ICD carefully against optimized medicines and LCSD, and it is not used on its own in someone without symptoms. Catheter ablation and gene therapies are being studied but are not standard care. Activity guidance is part of treatment. Competitive and high-intensity sports are generally discouraged. Low- to moderate-intensity activity may be possible once a person has been free of symptoms and exercise testing shows good control, with limits set individually, sometimes as a maximum heart rate. Avoiding sudden bursts of exertion, staying hydrated and avoiding overheating also help.

What to Expect

CPVT is a lifelong condition. Outlook depends heavily on diagnosis and consistent treatment, and arrhythmia risk is much lower when medicines are taken reliably and adjusted based on testing. The main daily commitments are taking medication every day without gaps, following the activity plan agreed with the cardiologist, and returning for regular checkups. Exercise stress tests are repeated to check that treatment is suppressing arrhythmias and to adjust doses, especially as children grow. Activity limits can be among the hardest parts, particularly for children and teenagers who enjoy sports. Plans are increasingly tailored rather than all-or-nothing, and they may loosen if testing shows good control over time. Schools, coaches and family members benefit from knowing about the condition and the emergency plan, including where the nearest AED (automated external defibrillator, a device that can shock the heart back into rhythm) is kept. The diagnosis can weigh heavily on the person and the family, and counseling or psychological support is worth arranging early. Because CPVT is inherited, a diagnosis often leads to testing of relatives and conversations about family planning, which a genetic counselor can help with. People planning a pregnancy should discuss it with their cardiologist ahead of time; beta-blockers are generally continued throughout pregnancy.

When to Seek Help

Anyone who faints, nearly faints or has a seizure-like episode during exercise, sports or a moment of strong emotion should be evaluated promptly by a doctor, especially a child or young adult, and especially when a relative died suddenly or unexpectedly at a young age. Ask specifically whether a heart rhythm problem has been considered. For someone already diagnosed, contact the heart rhythm team promptly after any fainting episode, new palpitations or near-fainting, or a single ICD shock after which the person feels well, since these can mean treatment needs adjusting. Tell the team right away if doses have been missed or the medicine is hard to take or tolerate. If someone collapses and does not respond, or is not breathing normally or is only gasping, call 911, start CPR right away and use an AED if one is available. More than one ICD shock in a short period, or a shock followed by fainting or feeling unwell, also needs 911. Family members, friends and coaches of people with CPVT benefit from learning CPR.

Questions to Ask Your Doctor

  1. 1.What did my exercise test show, and how will we use repeat tests to judge whether treatment is working?
  2. 2.Which kinds and intensities of physical activity are reasonable for me, and is there a heart rate I should stay under?
  3. 3.What should I do if I miss a dose of my beta-blocker, and what options are there if side effects make it hard to take?
  4. 4.Which of my relatives should be tested, and how would genetic testing and heart testing work for them?
  5. 5.Under what circumstances would you recommend flecainide, sympathetic denervation surgery or an ICD for me, and what are the trade-offs of each?

Last reviewed • Oct 2026

Educational content, not medical advice.